See more : Netac Technology Co., Ltd. (300042.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Fuji Pharma Co., Ltd. (4554.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fuji Pharma Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Sescom S.A. (SES.WA) Income Statement Analysis – Financial Results
- Apar Industries Limited (APARINDS.BO) Income Statement Analysis – Financial Results
- EQ Health Acquisition Corp. Red (EQHA-WT) Income Statement Analysis – Financial Results
- DCM Limited (DCM.BO) Income Statement Analysis – Financial Results
- Sunil Agro Foods Limited (SUNILAGR.BO) Income Statement Analysis – Financial Results
Fuji Pharma Co., Ltd. (4554.T)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.fujipharma.jp
About Fuji Pharma Co., Ltd.
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.89B | 35.43B | 33.99B | 33.79B | 36.28B | 37.91B | 35.39B | 34.23B | 31.68B | 29.22B | 25.17B | 21.52B | 21.62B | 19.70B | 17.20B | 14.94B |
| Cost of Revenue | 24.37B | 20.87B | 19.24B | 18.92B | 20.48B | 21.96B | 20.67B | 20.69B | 18.71B | 16.84B | 14.23B | 12.20B | 11.32B | 10.62B | 9.41B | 8.47B |
| Gross Profit | 16.52B | 14.56B | 14.75B | 14.87B | 15.80B | 15.95B | 14.72B | 13.54B | 12.97B | 12.38B | 10.94B | 9.32B | 10.30B | 9.08B | 7.80B | 6.47B |
| Gross Profit Ratio | 40.39% | 41.10% | 43.40% | 44.01% | 43.54% | 42.07% | 41.59% | 39.55% | 40.94% | 42.38% | 43.46% | 43.30% | 47.63% | 46.08% | 45.32% | 43.30% |
| Research & Development | 3.18B | 2.49B | 2.45B | 3.06B | 2.05B | 1.76B | 1.83B | 1.84B | 1.73B | 1.77B | 1.28B | 1.30B | 1.52B | 1.11B | 918.82M | 625.54M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.04B | 1.23B | 1.14B | 1.02B | 931.10M |
| Selling & Marketing | 0.00 | 0.00 | 1.35B | 1.49B | 1.89B | 1.82B | 1.54B | 1.26B | 1.41B | 1.13B | 1.04B | 1.03B | 968.24M | 723.44M | 621.65M | 431.01M |
| SG&A | 8.33B | 7.36B | 1.35B | 1.49B | 1.89B | 1.82B | 1.54B | 1.26B | 1.41B | 1.13B | 1.04B | 2.07B | 2.20B | 1.86B | 1.64B | 1.36B |
| Other Expenses | 1.14B | 8.29B | 7.61B | 7.18B | 7.68B | 93.00M | 9.00M | 27.00M | 18.00M | 65.00M | 52.00M | 24.26M | -2.99M | 8.38M | 11.18M | 14.13M |
| Operating Expenses | 12.66B | 10.78B | 11.40B | 11.73B | 11.62B | 11.56B | 10.40B | 9.96B | 9.72B | 9.20B | 7.68B | 5.82B | 5.96B | 5.14B | 4.67B | 3.78B |
| Cost & Expenses | 37.03B | 31.64B | 30.64B | 30.65B | 32.10B | 33.51B | 31.07B | 30.66B | 28.42B | 26.04B | 21.91B | 18.03B | 17.28B | 15.76B | 14.08B | 12.25B |
| Interest Income | 0.00 | 34.00M | 46.00M | 37.00M | 41.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00M | 1.72M | 2.41M | 4.91M | 9.58M |
| Interest Expense | 121.00M | 77.00M | 53.00M | 37.00M | 41.00M | 38.00M | 34.00M | 35.00M | 37.00M | 50.00M | 55.00M | 5.34M | 5.27M | 194.00K | 620.00K | 2.80M |
| Depreciation & Amortization | 3.02B | 2.75B | 2.11B | 2.06B | 2.13B | 2.25B | 2.02B | 1.92B | 2.08B | 1.65B | 1.41B | 1.21B | 1.02B | 1.03B | 952.27M | 803.05M |
| EBITDA | 7.54B | 6.52B | 5.46B | 5.20B | 6.30B | 6.64B | 6.34B | 5.49B | 5.33B | 4.83B | 4.68B | 3.54B | 4.52B | 4.97B | 3.42B | 3.52B |
| EBITDA Ratio | 18.45% | 19.29% | 15.91% | 15.02% | 17.15% | 17.83% | 18.89% | 15.21% | 16.46% | 16.78% | 19.24% | 21.67% | 24.72% | 25.25% | 23.77% | 23.53% |
| Operating Income | 3.86B | 3.78B | 3.35B | 3.14B | 4.17B | 4.39B | 4.31B | 3.57B | 3.25B | 3.17B | 3.26B | 3.49B | 4.34B | 3.94B | 3.12B | 2.69B |
| Operating Income Ratio | 9.44% | 10.66% | 9.85% | 9.29% | 11.50% | 11.58% | 12.19% | 10.42% | 10.26% | 10.86% | 12.95% | 16.24% | 20.07% | 19.98% | 18.14% | 18.00% |
| Total Other Income/Expenses | 541.00M | -54.00M | 22.00M | -221.00M | -212.00M | 81.00M | 216.00M | -420.00M | -146.00M | 59.00M | 71.00M | -1.17B | -803.48M | -781.05M | -651.68M | -659.18M |
| Income Before Tax | 4.40B | 3.72B | 3.37B | 2.92B | 3.96B | 4.47B | 4.53B | 3.15B | 3.11B | 3.23B | 3.33B | 2.33B | 3.50B | 3.16B | 2.47B | 2.03B |
| Income Before Tax Ratio | 10.76% | 10.51% | 9.92% | 8.63% | 10.92% | 11.80% | 12.80% | 9.20% | 9.80% | 11.06% | 13.24% | 10.81% | 16.17% | 16.02% | 14.36% | 13.59% |
| Income Tax Expense | 963.00M | 1.03B | 938.00M | 832.00M | 998.00M | 1.10B | 1.23B | 1.03B | 1.01B | 1.15B | 1.26B | 954.91M | 1.29B | 1.21B | 943.42M | 778.31M |
| Net Income | 3.44B | 2.70B | 2.43B | 2.09B | 2.96B | 3.37B | 3.30B | 2.12B | 2.09B | 2.08B | 2.07B | 1.37B | 2.20B | 1.94B | 1.53B | 1.25B |
| Net Income Ratio | 8.40% | 7.61% | 7.16% | 6.17% | 8.16% | 8.89% | 9.33% | 6.19% | 6.60% | 7.11% | 8.21% | 6.37% | 10.20% | 9.87% | 8.87% | 8.38% |
| EPS | 141.35 | 110.98 | 90.52 | 66.92 | 97.02 | 112.67 | 110.32 | 70.82 | 68.78 | 70.27 | 73.24 | 48.55 | 83.82 | 75.53 | 59.29 | 48.63 |
| EPS Diluted | 141.35 | 110.98 | 90.52 | 66.92 | 97.02 | 112.67 | 110.32 | 70.82 | 68.78 | 70.27 | 73.24 | 48.55 | 83.82 | 75.53 | 59.29 | 48.63 |
| Weighted Avg Shares Out | 24.30M | 24.29M | 26.87M | 31.16M | 30.53M | 29.93M | 29.93M | 29.92M | 30.42M | 29.59M | 28.24M | 28.24M | 26.31M | 25.74M | 25.74M | 25.74M |
| Weighted Avg Shares Out (Dil) | 24.30M | 24.29M | 26.87M | 31.16M | 30.53M | 29.93M | 29.93M | 29.92M | 30.42M | 29.59M | 28.24M | 28.24M | 26.31M | 25.74M | 25.74M | 25.74M |
Source: https://incomestatements.info
Category: Stock Reports